PFIZER AND BIONTECH RECEIVE EXPANDED U.S. FDA EMERGENCY USE AUTHORIZATION OF COVID-19 VACCINE BOOSTER TO INCLUDE INDIVIDUALS 18 AND OLDER
November 19, 2021
Expanded authorization allows more Americans to receive a booster dose to help preserve a high-level of protection against COVID-19
https://investors.pfizer.com/investor-news/press-release-details/2021/Pfizer-and-BioNTech-Receive-Expanded-U.S.-FDA-Emergency-Use-Authorization-of-COVID-19-Vaccine-Booster-to-Include-Individuals-18-and-Older/default.aspx